FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Unveiling the New and Improved Website
In today's fast-paced digital world, a company's online presence is often its first point of contact with customers. It's not just a [...]
A short history of CVBF
We are thrilled to invite you to watch the CVBF History Timeline Video to have a glimpse of our journey through the [...]
2023 iCAN Summit
Join us for an unforgettable experience at the 2023 iCAN Summit! We are excited to announce that our CEO, as a member [...]
CVBF September Special Issue
This new Special Issue is dedicated to the active involvement of CVBF in the European Joint Programme for Rare Diseases [...]
Scientific publication: Patient-Reported Outcome Measures in Clinical Research
The “Patient-Reported Outcome Measures in Clinical Research” research paper describes the importance and also some limitations of the use of [...]
European Research and Innovation Days 2022
The European Research and Innovation Days will take place online on 28 and 29 September 2022, allowing everyone to get [...]
Scientific publication: Ensuring a future for gene therapy for rare diseases
The paper “Ensuring a future for gene therapy for rare diseases” by Alessandro Aiuti, Francesca Pasinelli, and Luigi Naldini has [...]
Webinar: Paediatric diseases: research, biodrugs and territory
The Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM) of the National Research Council (CNR) in collaboration with the Consorzio per Valutazioni Biologiche e Farmacologiche [...]
Newsletter, AUGUST 2020
18th August 2020 Newsletter August 2020 EPTRI Stakeholders Roundtable was held on July: what are the future strategies of the paediatric research? On 9 July [...]
CVBF answered to the Public Consultation: Pharmaceuticals – safe and affordable medicines (new EU strategy)
The European Commission is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the [...]
CVBF is involved with the University of Pittsburgh in developing two vaccines for the coronavirus disease
We are glad to inform you that Consorzio per Valutazioni Biologiche e Farmacologiche will provide its contribution in the fight against COVID-19 emergency. It was [...]
COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines
EMA has now set up an infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines when used in day-to-day [...]
CVBF is involved in the multinational cASPerCF clinical trial
In the framework the c4c IMI2 funded project (pan European paediatric clinical trials network) cASPerCF study will be carried out. The study is being led [...]








